Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
Department of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands; 2 Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA; 3 Department of Epidemiology, Netherlands Institute of Mental Health and Addiction, Utrecht,The Netherlands; 4 Department of Translational Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands; 5 Department of Neurology, Brain Centre Rudolf Magnus, University Medical Centre Utrecht, Utrecht, The Netherlands; 6 Department of Psychiatry, Brain Centre Rudolf Magnus, University Medical Centre Utrecht, Utrecht, The Netherlands; 7 GGNet Mental Health, Apeldoorn, The Nether- lands; 8 Department of Psychosis Studies, King’s College London, Institute of Psychiatry, London, UK
Список исп. литературыСкрыть список
1. Correll CU, Galling B, Pawar A et al. Comparison of early intervention services vs treatment as usual for early-phase psychosis: a systematic review, meta-analysis, and meta-regression. JAMA Psychiatry 2018; 75: 555-65.
2. Srihari VH, Shah J, Keshavan MS. Is early intervention for psychosis feasible and effective? Psychiatr Clin North Am 2012; 35: 613-31.
3. van Os J, Guloksuz S. A critique of the “ultra-high risk” and “transition” paradigm. World Psychiatry 2017; 16: 200-6.
4. Fusar-Poli P, Schultze-Lutter F, Cappucciati M et al. The dark side of the moon: meta-analytical impact of recruitment strategies on risk enrichment in the clinical high risk state for psychosis. Schizophr Bull 2015; 42: 732-43.
5. Guloksuz S, van Os J. Need for evidence-based early intervention programmes: a public health perspective. Evid Based Ment Health 2018; 21: 128-30.
6. Yung AR, Wood SJ, Malla A et al. The reality of at risk mental state services: a response to recent criticisms. Psychol Med (in press).
7. McHugh MJ, McGorry P, Yuen H et al. The ultra-high-risk for psychosis groups: evidence to maintain the status quo. Schizophr Res 2018; 195: 543-8.
8. Schultze-Lutter F, Klosterkötter J, Gaebel W et al. Psychosis-risk criteria in the general population: frequent misinterpretations and current evidence. World Psychiatry 2018; 17: 107-8.
9. Perez J, Jones PB. Breaking the web: life beyond the at-risk mental state for psychosis. Psychol Med (in press).
10.Raballo A, Poletti M, Carpenter WT. Rethinking the psychosis threshold in clinical high risk. Schizophr Bull 2019; 45: 1-2.
11. Moritz S, Gawe˛da Ł, Heinz A et al. Four reasons why early detection centers for psychosis should be renamed and their treatment targets reconsidered: we should not catastrophize a future we can neither reliably predict nor change. Psychol Med 2019; 49: 2134-40.
12. Ajnakina O, David AS, Murray RM. ‘At risk mental state’ clinics for psychosis – an idea whose time has come – and gone! Psychol Med 2019; 49: 529-34.
13. Nelson B, Amminger GP, McGorry PD. Recent meta-analyses in the clinical high risk for psychosis population: clinical interpretation of findings and suggestions for future research. Front Psychiatry 2018; 9: 502.
14. McGorry PD, Mei C. Ultra-high-risk paradigm: lessons learnt and new directions. Evid Based Ment Health 2018; 21: 131-3.
15. Fusar-Poli P. The hype cycle of the clinical high risk state for psychosis: the need of a refined approach. Schizophr Bull 2018; 44: 250-3.
16. McGorry PD, Hartmann JA, Spooner R et al. Beyond the “at risk mental state” concept: transitioning to transdiagnostic psychiatry. World Psychiatry 2018; 17: 133-42.
17. Linscott R, Van Os J. An updated and conservative systematic review and meta-analysis of epidemiological evidence on psychotic experiences in children and adults: on the pathway from proneness to persistence to dimensional expression across mental disorders. Psychol Med 2013; 43: 1133-49.
18. Hanssen M, Bak M, Bijl R et al. The incidence and outcome of subclinical psychotic experiences in the general population. Br J Clin Psychol 2005; 44: 181-91.
19. Bromet EJ, Nock MK, Saha S et al. Association between psychotic experiences and subsequent suicidal thoughts and behaviors: a cross-national analysis from the World Health Organization World Mental Health Surveys. JAMA Psychiatry 2017; 74: 1136-44.
20. Yates K, Lång U, Cederlöf M et al. Association of psychotic experiences with subsequent risk of suicidal ideation, suicide attempts, and suicide deaths: a systematic review and meta-analysis of longitudinal population studies. JAMA Psychiatry 2019; 76: 180-9.
21. Oh H, Koyanagi A, Kelleher I et al. Psychotic experiences and disability: findings from the Collaborative Psychiatric Epidemiology Surveys. Schizophr Res 2018; 193: 343-7.
22. Rössler W, Riecher-Rössler A, Angst J et al. Psychotic experiences in the general population: a twenty-year prospective community study. Schizophr Res 2007; 92: 1-14.
23. Fonville L, Cohen Kadosh K, Drakesmith M et al. Psychotic experiences, working memory, and the developing brain: a multimodal neuroimaging study. Cereb Cortex 2015; 25: 4828-38.
24. McGrath JJ, Saha S, Al-Hamzawi A et al. The bidirectional associations between psychotic experiences and DSM-IV mental disorders. Am J Psychiatry 2016; 173: 997-1006.
25. Kirli U, Binbay T, Drukker M et al. DSM outcomes of psychotic experiences and associated risk factors: 6-year follow-up study in a community-based sample. Psychol Med 2019; 49: 1346-56.
26. Kelleher I, Keeley H, Corcoran P et al. Clinicopathological significance of psychotic experiences in non-psychotic young people: evidence from four population-based studies. Br J Psychiatry 2012; 201: 26-32.
27. Schultze-Lutter F, Michel C, Ruhrmann S et al. Prevalence and clinical relevance of interview-assessed psychosis-risk symptoms in the young adult community. Psychol Med 2018; 48: 1167-78.
28. de Graaf R, ten Have M, van Dorsselaer S. The Netherlands Mental Health Survey and Incidence Study-2 (NEMESIS-2): design and methods. Int J Methods Psychiatr Res 2010; 19: 125-41.
29. de Graaf R, ten Have M, van Gool C et al. Prevalence of mental disorders and trends from 1996 to 2009. Results from the Netherlands Mental Health Survey and Incidence Study-2. Soc Psychiatry Psychiatr Epidemiol 2012; 47: 203-13.
30. de Graaf R, Van Dorsselaer S, Tuithof M et al. Sociodemographic and psychiatric predictors of attrition in the third wave of the Netherlands Mental Health Survey and Incidence Study-2 (NEMESIS-2). Compr Psychiatry 2013; 54: 1131-9.
31. de Graaf R, Ormel J, Ten Have M et al. Mental disorders and service use in The Netherlands. Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD). New York: Cambridge University Press, 2008.
32. Alonso J, Angermeyer MC, Bernert S et al Sampling and methods of the European Study of the Epidemiology of Mental Disorders
(ESEMeD) project. Acta Psychiatr Scand 2004; 109: 8-20.
33. Nuyen J, Tuithof M, de Graaf R et al. The bidirectional relationship between loneliness and common mental disorders in adults: findings from a longi¬tudinal population-based cohort study. Soc Psychiatry Psychiatr Epidemiol (in press).
34. Radhakrishnan R, Guloksuz S, Ten Have M et al. Interaction between environmental and familial affective risk impacts psychosis admixture in states of affective dysregulation. Psychol Med 2019; 49: 1879-89.
35. Reininghaus U, Rauschenberg C, ten Have M et al. Reasoning bias, working memory performance and a transdiagnostic phenotype of affective disturbances and psychotic experiences in the general population. Psychol Med 2019; 49: 1799-809.
36. van Nierop M, Viechtbauer W, Gunther N et al. Childhood trauma is associated with a specific admixture of affective, anxiety, and psychosis symptoms cutting across traditional diagnostic boundaries. Psychol Med 2015; 45: 1277-88.
37. Pries L-K, Guloksuz S, ten Have M et al. Evidence that environmental and familial risks for psychosis additively impact a multidimensional subthreshold psychosis syndrome. Schizophr Bull 2018; 44: 710-9.
38. Bak M, Myin-Germeys I, Hanssen M et al. When does experience of psychosis result in a need for care? A prospective general population study. Schizoph Bull 2003; 29: 349-58.
39. Bijl RV, Ravelli A. Psychiatric morbidity, service use, and need for care in the general population: results of The Netherlands Mental Health Survey and Incidence Study. Am J Public Health 2000; 90: 602-7.
40. Pries LK, Lage-Castellanos A, Delespaul P et al. Estimating exposome score for schizophrenia using predictive modeling approach in two independent samples: the results from the EUGEI study. Schizophr Bull 2019; 45: 960-5
41. Guloksuz S, Pries LK, Delespaul P et al. Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study. World Psychiatry 2019; 18: 173-82.
42. Efron B. The efficiency of Cox's likelihood function for censored data. J Am Stat Assoc 1977; 72: 557-65.
43. Lin DY, Wei L-J. The robust inference for the Cox proportional hazards model. J Am Stat Assoc 1989; 84: 1074-8.
44. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika 1982; 69: 239-41.
45. VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med 2017; 167: 268-74.
46. Newson RB. Attributable and unattributable risks and fractions and other scenario comparisons. Stata J 2013; 13: 672-98.
47. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health 1998; 88: 15-9.
48. Albert U, Tomassi S, Maina G et al. Prevalence of non-psychotic disorders in ultra-high risk individuals and transition to psychosis: a systematic review. Psychiatry Res 2018; 270: 1-12.
49. Fusar-Poli P, Nelson B, Valmaggia L et al. Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis. Schizophr Bull 2012; 40: 120-31.
50. Addington J, Piskulic D, Liu L et al. Comorbid diagnoses for youth at clinical high risk of psychosis. Schizophr Res 2017; 190: 90-5.
51. Tanuseputro P, Perez R, Rosella L et al. Improving the estimation of the burden of risk factors: an illustrative comparison of methods to measure smoking-attributable mortality. Popul Health Metr 2015; 13: 5.
52. Jongsma HE, Turner C, Kirkbride JB et al. International incidence of psychotic disorders, 2002-17: a systematic review and meta-analysis. Lancet Public Health 2019; 4: e229-44.
53. van Os J, Guloksuz S, Vijn TW et al. The evidence-based group-level symptom-reduction model as the organizing principle for mental health care: time for change? World Psychiatry 2019; 18: 88-96.